CONCLUSIONS: RARC with hybrid neobladder reconstruction is technical feasible and achieves favorable safety outcomes. Hybrid reconstruction allows a better control of the ileal anastomosis and a reduction of surgical time, retaining the advantages of mini-invasivity and intracorporeal ureteral and urethral anastomosis. Moreover, the use of GelPOINT device and early clamping of the urethra may increase oncological safety. METHODS: After approval by the Institutional Review Board, we included all consecutive patients who underwent perineal urethrectomy with simultaneous robotic assisted radical cystectomy (RARC) and intracorporeal ileal conduit (ICIC) with the Da Vinci Xi robot, in our institution from January 1st 2018 to September 15th 2018. We compared per-operative data with another group of patients that underwent RARC with ICIC without urethrectomy in our institution during the same period.
INTRODUCTION AND OBJECTIVES:
To describe the feasibility and time effectiveness of simultaneous perineal urethrectomy and robotic cystectomy with total intracorporeal ileal conduit.
METHODS: After approval by the Institutional Review Board, we included all consecutive patients who underwent perineal urethrectomy with simultaneous robotic assisted radical cystectomy (RARC) and intracorporeal ileal conduit (ICIC) with the Da Vinci Xi robot, in our institution from January 1st 2018 to September 15th 2018. We compared per-operative data with another group of patients that underwent RARC with ICIC without urethrectomy in our institution during the same period.
RESULTS: In total, there were 2 patients in the simultaneous urethrectomy group and 14 patients in the no urethrectomy group. Extended lymph node dissection was done for all patients in both groups. Firefly was used for the urinary diversion in all cases in both groups. There was no significant difference between the operative time in the simultaneous urethrectomy group (370 min) and the no urethrectomy group (360 min) (p[0.09).
CONCLUSIONS: Perineal urethrectomy with simultaneous RARC and ICIC is a feasible and time efficient procedure similar to RARC and ICUD without perineal urethrectomy. METHODS: We report a 58-year-old female who suffered from left chest pain initially. Gross hematuria developed later. Abdominal CT and renal MRI disclosed diffusely infiltrating right renal tumor with right renal vein and level II IVC thrombus. Chest CT revealed a left lung tumor then the pathology report of the lung biopsy disclosed metastatic urothelial carcinoma. We performed robot-assisted palliative nephroureterectomy with bladder cuff excision and IVC thrombectomy.
RESULTS: The peri-and postoperative periods were uneventful. The final pathology was poorly differentiated variant of urothelial carcinoma which invaded the renal parenchyma, renal vein and IVC.
CONCLUSIONS: We would like to share this unusual variant of urothelial carcinoma with even rare IVC tumor thrombus and the feasibility with safety of robotic IVC thrombectomy.
Source of Funding: none

V06-11 URETERO NEOBLADDER REIMPLANTATION USING THE DA VINCI XI ROBOT AND THE FIREFLYÒ SYSTEM
Stefan Jeglinschi*, Brannwel Tibi, Daniel Chevallier, Matthieu Durand, Youness Ahallal, Nice, France INTRODUCTION AND OBJECTIVES: To describe the feasibility of robotic uretero-neobladder reimplantation using Indocyanine Green (ICG) and blue dye in order to treat uretero-neobladder stenosis.
METHODS: The patient was a 66-year-old male with a congenital solitary right kidney that was first treated with robotic radical cystectomy and intra corporeal Studer orthotopic ileal neobladder. A right nephrostomy tube was performed at 1 month to treat a uretero-neobladder stenosis. A robotic right uretero-neobladder reimplantation was performed by injecting ICG and blue dye through the nephrostomy to aid ureteral dissection and blue dye through the urinary catheter to aid neobladder identification. A uretero-neobladder anastomosis was performed after a per operative JJ stent was inserted.
RESULTS: Operative time was 60 min. Per-operative blood loss was 100cc. The nephrostomy tube was removed on day 2. Return to bowel function was 2 days for gaz and 3 days for stool. Length of hospital stay was 3 days. The urinary catheter was removed on day 14. The JJ stent was removed on day 21. The were no post operative complications with a follow up of 6 months.
CONCLUSIONS: Robotic uretero-neobladder reimplantation using ICG and blue dye is a feasible option to treat uretero-neobladder stenosis allowing a better ureteral and neobladder identification. 
